EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autoimmune Neuromuscular Disorders at a Molecular Crossroad: Linking Pathogenesis to Targeted Immunotherapy

Anca-Maria Florea, Dimela-Gabriela Luca, Eugenia Irene Davidescu iD, Bogdan-Ovidiu Popescu iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311736 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anca-Maria Florea und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania. Hauptthemen laut MEDLINE: Immunotherapy, Neuromuscular Diseases, Autoimmune Diseases. Die Arbeit nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania, Department of Research and Grants, Romanian Ministry of Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and idiopathic inflammatory myopathies are among the most widely recognized autoimmune neuromuscular disorders. Although they differ in clinical presentation, shared immunopathogenic mechanisms place them at a molecular crossroads. Evidence of overlapping pathways has led to the development of targeted strategies including complement inhibition, FcRn antagonism, B-cell depletion, and the CAR-T cell approach. In this review, we analyze current knowledge regarding pathogenic mechanisms and their link to immunotherapy, extensively outlining both similarities and distinctions. We further discuss existing challenges, including diagnostic limitations and refractory disease variants, how technological advances have already addressed some of these issues, and where further progress is still needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyNeuromuscular DiseasesAutoimmune DiseasesHumansAnimalsMyasthenia Gravis

Stichwörter der Autor:innen

B-cell depletion therapyFcRn antagonistsautoantibodieschronic inflammatory demyelinating polyneuropathycomplement inhibitionidiopathic inflammatory myopathiesmyasthenia gravistargeted immunotherapy

Autor:innen und Institutionen

  • Department of Clinical Neurosciences, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
  • Department of Neurology, Colentina Clinical Hospital, 020125 Bucharest, Romania.
  • Department of Cell Biology, Neurosciences and Experimental Myology, "Victor Babes" National Institute of Pathology, 050096 Bucharest, Romania.

ORCID-Profile: Eugenia Irene Davidescu, Bogdan-Ovidiu Popescu

Förderung

  • “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania, Department of Research and Grants
  • Romanian Ministry of Research and Innovation

Zitieren

APA

Florea, A. M., Luca, D. G., Davidescu, E. I., & Popescu, B. O. (2025). Autoimmune Neuromuscular Disorders at a Molecular Crossroad: Linking Pathogenesis to Targeted Immunotherapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311736

Vancouver

Florea AM, Luca DG, Davidescu EI, Popescu BO. Autoimmune Neuromuscular Disorders at a Molecular Crossroad: Linking Pathogenesis to Targeted Immunotherapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311736

BibTeX
@article{Florea2025,
  author = {Florea, Anca-Maria and Luca, Dimela-Gabriela and Davidescu, Eugenia Irene and Popescu, Bogdan-Ovidiu},
  title = {Autoimmune Neuromuscular Disorders at a Molecular Crossroad: Linking Pathogenesis to Targeted Immunotherapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311736}
}
Kostenlos starten →